Split Federal Circuit Won’t Reconsider Antibody Patent JMOL Reversal
WASHINGTON, D.C. — Over the objections of one circuit judge, the Federal Circuit U.S. Court of Appeals denied a petition from Eli Lilly and Co. (Lilly) for rehearing en banc and...To view the full article, register now.
Already a subscriber? Click here to view full article